We are live on
!
Find out more
Vanguard Group Portfolio holdings
AUM
$6.9T
Turnover
4.07%
1-Year Est. Return
27.45%
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
This Fund
S&P 500
This Quarter
Est. Return
+14.09%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$6.18T
AUM Growth
+$647B
(+12%)
Cap. Flow
+$78.1B
Cap. Flow
% of AUM
1.26%
Top 10 Holdings %
Top 10 Hldgs %
28.81%
Holding
4,383
New
103
Increased
2,425
Reduced
1,410
Closed
108
Avg Time Held
8.1
years
Top 10 Avg Time Held
4.8
years
Top 20 Avg Time Held
6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.95B |
| 2 |
NVIDIA
NVDA
|
+$4.97B |
| 3 |
Capital One
COF
|
+$4.5B |
| 4 |
Amazon
AMZN
|
+$3.45B |
| 5 |
Flutter Entertainment
FLUT
|
+$3.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Discover Financial Services
DFS
|
+$5.32B |
| 2 |
Intra-Cellular Therapies Inc.
ITCI
|
+$1.26B |
| 3 |
Amphenol
APH
|
+$1.18B |
| 4 |
Welltower
WELL
|
+$987M |
| 5 |
US Steel
X
|
+$825M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.14% |
| 2 | Financials | 14% |
| 3 | Consumer Discretionary | 10.14% |
| 4 | Healthcare | 9.38% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3476
Stem
STEM
$35.6M
| $2.41M | ﹤0.01% |
386,755
-44,012
| -10% | -$395K |
2021 Q2
16 quarters
|
|
3477
AIRO Group Holdings
AIRO
$173M
| $2.41M | ﹤0.01% |
+100,000
| New | +$2.54M |
2025 Q2
0 quarters
|
|
3478
RF Industries
RFIL
$79.4M
| $2.4M | ﹤0.01% |
371,123
| – | – |
2013 Q3
47 quarters
|
|
|
IRLA
3479
IRulya Therapeutics Inc. Common Stock
IRLA
$33.8M
| $2.4M | ﹤0.01% |
7,270
+841
| +13% | +$192K |
2019 Q2
24 quarters
|
|
3480
Hyperfine
HYPR
$82.7M
| $2.39M | ﹤0.01% |
3,321,836
| – | – |
2022 Q1
13 quarters
|
|
3481
Alto Neuroscience
ANRO
$888M
| $2.39M | ﹤0.01% |
1,084,705
-133,940
| -11% | -$319K |
2024 Q1
5 quarters
|
|
3482
DELISTED
First Seacoast Bancorp
FSEA
| $2.38M | ﹤0.01% |
210,698
+4,496
| +2% | +$50.1K |
2022 Q2
12 quarters
|
|
3483
AmeriServ Financial
ASRV
$75.7M
| $2.37M | ﹤0.01% |
780,935
+58,554
| +8% | +$151K |
2013 Q2
48 quarters
|
|
3484
Strive Inc
ASST
$2.59B
| $2.37M | ﹤0.01% |
+31,641
| New | +$2.56M |
2025 Q2
0 quarters
|
|
3485
Vanguard Morningstar Small-Cap Growth ETF
VBK
$22.7B
| $2.37M | ﹤0.01% |
8,567
-53
| -0.6% | -$13.6K |
2023 Q2
8 quarters
|
|
3486
Fuel Tech
FTEK
$44.3M
| $2.37M | ﹤0.01% |
940,969
| – | – |
2013 Q2
48 quarters
|
|
3487
Pyxis Oncology
PYXS
$150M
| $2.36M | ﹤0.01% |
2,149,396
-287,332
| -12% | -$324K |
2021 Q4
14 quarters
|
|
3488
Elutia
ELUT
$34.9M
| $2.34M | ﹤0.01% |
1,180,505
+191,900
| +19% | +$388K |
2020 Q4
18 quarters
|
|
3489
iShares Russell Mid-Cap Value ETF
IWS
$15.4B
| $2.34M | ﹤0.01% |
17,681
-123
| -0.7% | -$15.4K |
2023 Q2
8 quarters
|
|
3490
National Energy Services Reunited Corp
NESR
$1.93B
| $2.33M | ﹤0.01% |
+386,822
| New | +$2.4M |
2025 Q2
0 quarters
|
|
3491
Cato Corp
CATO
$47M
| $2.31M | ﹤0.01% |
822,162
-18,491
| -2% | -$49.1K |
2013 Q2
48 quarters
|
|
3492
PrimeEnergy Resources
PNRG
$323M
| $2.3M | ﹤0.01% |
15,736
-16,776
| -52% | -$2.91M |
2017 Q4
30 quarters
|
|
3493
DELISTED
Sandstorm Gold
SAND
| $2.3M | ﹤0.01% |
244,204
+20,502
| +9% | +$176K |
2015 Q1
41 quarters
|
|
3494
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.9B
| $2.29M | ﹤0.01% |
13,953
-825
| -6% | -$131K |
2023 Q1
9 quarters
|
|
3495
Telkom Indonesia
TLK
$12.6B
| $2.29M | ﹤0.01% |
135,171
-4,207
| -3% | -$67.4K |
2014 Q4
42 quarters
|
|
3496
GCT Semiconductor Holding
GCTS
$162M
| $2.28M | ﹤0.01% |
1,533,001
+651,060
| +74% | +$879K |
2024 Q2
4 quarters
|
|
3497
PMV Pharmaceuticals
PMVP
$69M
| $2.28M | ﹤0.01% |
2,153,600
-21,461
| -1% | -$21.1K |
2020 Q3
19 quarters
|
|
3498
DELISTED
Mersana Therapeutics
MRSN
| $2.27M | ﹤0.01% |
307,136
-27,975
| -8% | -$246K |
2017 Q2
32 quarters
|
|
3499
Suzano
SUZ
$10.3B
| $2.27M | ﹤0.01% |
241,245
+113,672
| +89% | +$1.04M |
2024 Q4
2 quarters
|
|
3500
Altisource Portfolio Solutions
ASPS
$63.8M
| $2.27M | ﹤0.01% |
265,706
+169,111
| +175% | +$1.23M |
2013 Q2
48 quarters
|
|
Similar funds
Vanguard Group's Q2 2025 Portfolio in Review
As of Q2 2025, Vanguard Group held 4,383 positions worth $6.18T, up 12% from $5.53T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q2 2025: portfolio turnover was 4.8%. Vanguard Group opened 103 new positions and exited 108, leaving the 4,383-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Discretionary.
- Vanguard Group's largest Q2 2025 buy was Amrize Ltd: 21,350,540 shares worth $1.07B.
- Vanguard Group added most to Microsoft in Q2 2025, an estimated $5.95B increase.
- Vanguard Group's biggest Q2 2025 reduction was Amphenol, cutting an estimated $1.18B.
- Vanguard Group fully exited Discover Financial Services in Q2 2025, selling an estimated $5.32B.
- Vanguard Group's ten largest holdings make up 29% of its $6.18T portfolio in Q2 2025.
- Vanguard Group opened 103 new positions and closed 108 in Q2 2025.
- Vanguard Group's portfolio value rose 12% quarter-over-quarter to $6.18T.
Based on Vanguard Group's 13F filing for Q2 2025, filed 11 Aug 2025.